Olivia Vanessa Seraphim

Since joining Kirkland, Olivia has been involved in the following matters:

• Rite Aid Corporation (“Rite Aid”) and 119 of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey.
• Eli Lilly in its $1.4 billion acquisition of POINT Biopharma Global Inc.
• Thoma Bravo, a leading software investment firm, in its acquisition of Bluesight, the Medication Intelligence™ Company.
• Thoma Bravo in Bluesight’s acquisition of Medacist, a pioneer in drug diversion monitoring VSP Vision on acquisition of Professional Eye Care Associates of America.
• HGGC in its acquisition of Dentive, LLC, a dental services organization.
• TPG Growth, LLC in its partnership with Novant Health to expand MedQuest Associates.
• Oak Street Health (NYSE: OSH) in its $10.6 billion sale to CVS Health (NYSE: CVS).
• VSP Vision in its acquisition of Professional Eye Care Associates of America.
• Thoma Bravo in its strategic growth investment in Circle Cardiovascular Imaging, the global leader in cardiovascular imaging solutions. 
• Maravai LifeSciences, Inc. in its acquisition of MyChem, LLC. 
• Gryphon Investors in its acquisition of Metagenics.
• One Equity Partners in its investment in Infucare RX.
• Clayton, Dubilier & Rice, LLC in its investment in Vera Whole Health. 
• Incline Equity Partners in its investment in Revival Animal Health.
• Vestar Capital Partners in its investment in Friday Health Plans.
• Vitruvian Partners in its acquisition of a majority stake in KCAS Bioanalytical and Biomarker Services, an Integris Bioservices, LLC company.
• Carlyle Group in its diversture of Newport Academy.
• Vista Equity Partners in its investment in iN2L.

Prior to joining Kirkland, Olivia was involved in the following:

• Part of the team representing Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its acquisition of Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million.
• Provided healthcare regulatory advice to Triple Tree Capital Partners, Noro Moseley Partners and SSM Partners in the formation of its holding company, Riva Health Holdings, Inc., a newly formed holding company that facilitated the merger of Revel and NovuHealth. Riva Health Holdings, Inc., combined through Triple ree Capital Partners portfolio company – Revel – and Noro Moseley Partners and SSM Partners portfolio company – NovuHealth – forms the largest technology platform company focused on healthcare member engagement.
• Part of team representing Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its acquisition of A Plus Health Care, Inc., a provider of home care services, including personal care, private duty nursing, care management and medical staffing. Terms of the transaction were not disclosed.